Log In Get Started
Press Releases June 1, 2026 05:00 PM

embecta to Participate in Investor Events

Embecta Corp. Announces Participation in Multiple Major Investor Conferences in June 2026

By Sofia Navarro EMBC

Embecta Corp., a global medical supplies company with a legacy in insulin delivery, announced that its management will participate in several prominent investor events in June 2026, including the Jefferies Global Healthcare Conference, TD Cowen Diabetes Tech Summit, Goldman Sachs Annual Global Healthcare Conference, and Truist Securities MedTech Conference. These events aim to engage investors and showcase the company’s strategies and innovations.

embecta to Participate in Investor Events
EMBC

Key Points

  • Embecta’s management to host investor meetings and a fireside chat at multiple leading healthcare and medical technology conferences.
  • The company emphasizes its transition from insulin delivery to a broader medical supplies provider with innovative solutions.
  • Events are to be held in major cities including New York, New Orleans, Miami, and Boston, reflecting a proactive investor relations strategy.

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:

2026 Jefferies Global Healthcare Conference

  • Management will host one-on-one investor meetings on Wednesday, June 3, 2026, at the Marriott Marquis, New York City.

TD Cowen Diabetes Tech Summit

  • Management will host a fireside session on Friday, June 5, 2026, at 9:40 a.m. CT / 10:40 a.m. ET, at the Westin New Orleans, LA.

2026 Goldman Sachs 47th Annual Global Healthcare Conference

  • Management will host one-on-one investor meetings on Tuesday, June 9, 2026, at the Loews Miami Beach Hotel, Miami, FL.

2026 Truist Securities MedTech Conference

  • Management will host one-on-one investor meetings on Tuesday, June 16, 2026, at the Boston Harbor Hotel, MA.

About embecta 

embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,500 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts:

MediaInvestorsChristian GlazarPravesh KhandelwalSr. Director, Corporate CommunicationsVP, Head of Investor Relations908-821-6922551-264-6547Contact Media RelationsContact IR



Risks

  • Market and investor response to these presentations is uncertain and may not lead to immediate stock price appreciation.
  • Broader challenges in the healthcare and medical supplies sector could impact Embecta’s future performance despite investor engagement.
  • The company’s successful transition from insulin delivery to diversified medical supplies depends on execution and market receptivity, which carries inherent uncertainties.

More from Press Releases

LiqTech International Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Jun 4, 2026 Correction: Keystone Acquisition Corp. Announces Closing of $287.5 Million Initial Public Offering Including Exercise of Underwriters’ Over-Allotment Option Jun 4, 2026 Verizon declares quarterly dividend on June 4, 2026 Jun 4, 2026 AmperCap Acquisition Company Completes its $125,000,000 Initial Public Offering Jun 4, 2026 Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026